$CELG Company News Bull rolls on, but opportunities

New Post Public Reply Private Reply Replies (0) Message Board

Jul 14, 2014 at 10:40 AM

$CELG Company News

Bull rolls on, but opportunities start to dwindle 1:52 p.m. July 10, 2014 - The Trading Deck
Reynolds rises on buyout report; Delta gains altitude 2:25 p.m. July 9, 2014 - Sue Chang
Celgene's arthritis drug fails a test, but company's stock rises anyway 1:23 p.m. July 9, 2014 - Russ Britt
Celgene shares slump as late-stage trial misses goal 7:27 a.m. July 9, 2014 - Ciara Linnane
S&P, Dow rattle cage on uncharted territory 11:20 a.m. July 1, 2014 - Michael Ashbaugh
S&P, Dow rattle cage on uncharted territory 10:54 a.m. July 1, 2014 - Michael Ashbaugh
Celgene's fourth stock split is a hit with investors as shares climb 1:02 p.m. June 19, 2014 - Russ Britt
Celgene shareholders approve 2-for-1 stock split 8:57 a.m. June 19, 2014 - Ciara Linnane
Celgene to increase buyback program to 1.15 bln shares from 575 mln 8:52 a.m. June 19, 2014 - Ciara Linnane
Celgene shareholders approve 2-for-1 stock split 8:51 a.m. June 19, 2014 - Ciara Linnane
Celgene drops 1.9%, among worst S&P 500 losers 9:32 a.m. May 29, 2014 - Sue Chang
Higher rates are coming — here’s how you prepare 8:38 a.m. May 12, 2014 - Jeff Reeves
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap 4:03 p.m. April 29, 2014 - blogs.marketwatch.com
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Sue Chang
What ‘Game of Thrones’ can teach you about money 8:30 a.m. April 5, 2014 - Wallace Witkowski
Biotechs, bonds and more from the 'tempest in a microsecond' 8:32 a.m. April 2, 2014 - Shawn Langlois
Play-it-safe stock investors may take some risk on jobs 8:31 a.m. March 30, 2014 - Wallace Witkowski
Nasdaq pullback rife with opportunity 2:07 p.m. March 25, 2014 - The Trading Deck
44 stocks on takeover target radar: Morgan Stanley 12:48 p.m. March 25, 2014 - blogs.marketwatch.com
Biotech comeback stalls as Wall Street starts to worry 12:45 p.m. March 25, 2014 - Russ Britt

3 Biotech Stocks That Belong in Your Portfolio 4:45 a.m. Today - InvestorPlace.com
A Contrarian's Take 2:07 a.m. July 12, 2014 - Barrons.com
Oncolytics Up on Patient Enrolment Completion - Analyst Blog 3:00 p.m. July 11, 2014 - Zacks.com
Buying The Dip - The Game Plan 11:41 a.m. July 10, 2014 - Seeking Alpha
Celgene's Otezla Disappoints in Ankylosing Spondylitis Study - Analyst Blog 11:30 a.m. July 10, 2014 - Zacks.com
Cramer's Mad Money - The 4 Horsemen Of Biotech Ride On (7/9/14) 6:27 a.m. July 10, 2014 - Seeking Alpha
Jim Cramer's Top Stock Picks: WMB AA BIIB REGN CELG GILD UNUM 6:00 a.m. July 10, 2014 - TheStreet.com
'Fast Money' Recap: Digging Into Oil Prices 5:00 a.m. July 10, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Hunting for Bargains 7:53 p.m. July 9, 2014 - TheStreet.com
Pluristem Initiates Trial in South Korea - Analyst Blog 6:00 p.m. July 9, 2014 - Zacks.com
3 Drugs Stocks Driving The Industry Higher 1:03 p.m. July 9, 2014 - TheStreet.com
Two Analysts Don't See Celgene's Weak Trial Results As A Huge Setback 11:37 a.m. July 9, 2014 - benzinga.com
Celgene Drug Otezla Fails Trial, But Street Sanguine 10:52 a.m. July 9, 2014 - Investors Business Daily
Celgene Slips; Drug Candidate Fails Phase III Trial Endpoint 8:37 a.m. July 9, 2014 - benzinga.com
Celgene's Phase 3 Study of Arthritis Drug Misses Target 7:51 a.m. July 9, 2014 - The Wall Street Journal Interactive Edition
UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings 7:49 a.m. July 9, 2014 - 247WallSt.com
Otezla fails to hit primary endpoint in Phase 3 label expansion trial 7:28 a.m. July 9, 2014 - Seeking Alpha
AbbVie Raises Offer for Shire 7:22 p.m. July 8, 2014 - The Wall Street Journal Interactive Edition
Alexion Pharma Looks To Life Beyond Its Blockbuster 1:42 p.m. July 8, 2014 - Investors Business Daily
3 Stocks Reiterated As A Buy: BMY, CAT, CELG 12:29 p.m. July 8, 2014 - TheStreet.com

Celgene Reports Results from the Phase III POSTURE Study Evaluating Oral OTEZLA® in Ankylosing Spondylitis 7:00 a.m. July 9, 2014 - BusinessWire - BZX
Biotech Stocks Highlight -- Research on Celgene, Inovio Pharma, Amgen, and Array BioPharma 6:40 a.m. July 9, 2014 - PR Newswire - PRF
Clinical Trials, Petitions, and Upcoming Earnings Releases - Analyst Notes on Celgene, Covidien, AbbVie, Teva and Thermo Fisher Scientific 5:40 a.m. July 8, 2014 - PR Newswire - PRF
Celgene Corporation to Announce Second Quarter 2014 Results on July 24, 2014 8:31 a.m. July 1, 2014 - BusinessWire - BZX
CORRECTING and REPLACINGCelgene Corporation Mourns the Passing of Board of Director Member, Rodman L. Drake 2:28 p.m. June 26, 2014 - BusinessWire - BZX
Companies Chasing Gold Nugget of Immuno-Oncology Like Never Before 9:37 a.m. June 26, 2014 - ACCESSWIRE
Celgene Corporation Mourns the Passing of Board of Director Member, Rodman L. Drake 8:30 a.m. June 26, 2014 - BusinessWire - BZX
Celgene Stockholders Approve Two-for-One Stock Split 8:30 a.m. June 19, 2014 - BusinessWire - BZX
Results from Phase III Study (AML-001) of VIDAZA® (Azacitidine for Injection) in Acute Myeloid Leukemia Presented at EHA 8:58 a.m. June 14, 2014 - BusinessWire - BZX
Studies Presented at 19th European Hematology Association Annual Congress Evaluate Activin Receptor Ligand Trap Programs in Beta-Thalassemia 3:00 a.m. June 14, 2014 - BusinessWire - BZX
Analysis of Health-Related Quality of Life Measures from the MM-020/IFM 07-01 (FIRST®) Trial Presented at EHA Annual Congress 5:44 p.m. June 13, 2014 - BusinessWire - BZX
Critical Alerts For JC Penney, Brown Forman, Schlumberger, Celgene, and DirecTV Technology Released By InvestorsObserver 9:31 a.m. June 11, 2014 - PR Newswire - PRF
Oral OTEZLA® (Apremilast) Showed Long-Term Clinical Benefits in Patients with Active Psoriatic Arthritis 7:30 a.m. June 11, 2014 - BusinessWire - BZX
Oral OTEZLA® (Apremilast) Monotherapy Showed Long-Term Clinical Benefits in DMARD-Naïve Patients with Active Psoriatic Arthritis 7:30 a.m. June 11, 2014 - BusinessWire - BZX
Health Care Sector Equities Coverage -- Research on Neurocrine Biosciences, PDL BioPharma, Celgene, and Array BioPharma 7:50 a.m. June 6, 2014 - PR Newswire - PRF
Post-Hoc Analysis of Overall Survival in Phase III MPACT Study of Patients with Advanced Pancreatic Cancer Presented at ASCO 2014 9:01 a.m. June 1, 2014 - BusinessWire - BZX
Veracyte, Foundation Medicine and Panacea Global Paving Way in Faster, More Accurate Cancer Diagnostics 9:53 a.m. May 29, 2014 - ACCESSWIRE
Breakthrough Innovation for Animal Health, Upcoming Conference Presentations, and New Treatment Options for Patients - Analyst Notes on Merck, Actavis, Celgene, Bristol-Myers Squibb and GSK 5:50 a.m. May 29, 2014 - PR Newswire - PRF
Organizational Changes Strengthen and Expand Celgene Leadership Team 6:00 a.m. May 22, 2014 - BusinessWire - BZX
Marketing Authorizations, Study Results Presentations, FDA Response to Drug Application, and New Messaging Services - Analyst Notes on Johnson & Johnson, Merck, Celgene, Novartis and UnitedHealth 8:41 a.m. May 21, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NABEP's Strategic Push: 41 Rigs to Bolster Output

On The Ground: NABEP's Expanding Venezuelan Presence Think of oil production as a high-stakes poker game where each drill and rig is a well-placed bet. North American Blue Energy Partners (NABEP) is going all in on Venezuela, boosting their rig fleet and pushing production capacity to new heights. Set your sights on November when NABEP's in-country fleet will hit 41 rigs...

Decoding Real Estate Value: A Market Insider's Take

Riding the Waves of Real Estate Pricing Homeowners dipping their toes into the real estate market know that setting the right price ain't a walk in the park. Luckily, Matt Nuzie, Shelton's real estate pro, has peeled back the layers on comparative market analyses (CMA) in a HelloNation piece. This isn't just about tossing a number out there—it's about understanding the...

Smart Salary Moves for S Corp Owners: Riggs Unpacks Insights

Decoding the S Corp Salary Dance How much salary should the savvy owners of S corporations draw? It ain't a simple task or one-size-fits-all deal, folks. David Riggs spills the beans on HelloNation, sharing insights on this complex tango between drawing wages and raking in shareholder distributions. In the end, it’s about playing by the IRS rules—or risking a penalty...

Decoding LRV: Smart Paint Choices for Your Home

Unraveling the Secrets of LRV Nobody thought analyzing paint meant diving into light reflectance values (LRV), but that's precisely where we're headed today. Painting a room seems simple until you realize your color choice might turn your bright haven into a cave or vice versa. Thanks to some insights from Wendy Anguiano in HelloNation, let's dig into this technical...

TESSAN and Jamie Leibert's Daring Alpine Documentary Launch

Steps Beyond the Obvious Adventure Launching headlong into the unknown—literally and figuratively—is what the documentary Jump Into The Unknown captures. TESSAN and Jamie Leibert have peeled back the curtain on adventure, showing us that it’s not just about the destination, but every twist, turn, and recalibrated step in between. The Backstory Behind Every Jump...

Ensuring Flooring Stability: Acclimation's Key Role

Dive into the World of Flooring Acclimation You ever hear about flooring acclimation? Sounds as riveting as watching paint dry, right? But Austin J. Messina from Salem, New Hampshire, is here to tell us it's the secret to flooring that doesn't buckle under pressure—literally. Messina's insights, splashed across the pages of HelloNation, delve deep into the nitty-gritty...

Navigating the Maze of Required Minimum Distributions

Understanding Required Minimum Distributions Ever felt like retirement planning is walking a financial tightrope? Well, when it comes to Required Minimum Distributions (RMDs), you're tiptoeing on a wire. These IRS-mandated withdrawals aren't just accounting quirks; they’re a cornerstone of retirement income strategy—a fact unmistakably highlighted by Janie Kelly in...

OlloBot's Emotional AI Robots Connect Beyond Tasks

OlloBot Eyes Emotional Bonds, Not Just Robotics Power Is it just me, or is OlloBot onto something deep with their emotional AI companions? They've set a course that might just redefine how we perceive home robotics. At IFA Berlin 2026, they didn't just strut their technical stuff. Nope, they took it beyond gears and gadgets, turning heads with a robot that does more than...

CJ BIO's Bold Steps for Sustainable Animal Nutrition

Breaking New Ground in Animal Nutrition Picture this: industry big wigs and farmers alike, all rubbing elbows at EuroTier 2026, the grand meeting ground for animal nutrition's future. This is where CJ BIO is flexing its muscles, not by just tossing ingredients into the mix, but by revolutionizing them under the banner "Feed Intelligence for Sustainable Performance." Now,...

Chiropractic Insights: Differentiating Piriformis vs. Disc Pain

Understanding Pain: Two Paths, One Problem Buttock and leg pain is a real drag, isn't it? We often brush it off as sciatica, but here's a twist: it might not be the usual corporate villain—a herniated disc. Instead, we could be dealing with an underdog called piriformis syndrome. According to Dr. Mitch Quill, D.C., of HelloNation fame, understanding these nuances isn't...